Edition:
United States

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

16.08USD
18 Sep 2018
Change (% chg)

-- (--)
Prev Close
$16.08
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,897
52-wk High
$18.88
52-wk Low
$6.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jul 3.72 -0.466
FY 2018 Apr '18 4.84 -0.061
Jan '18 2.33 -0.485
Oct 1.13 -0.498
Jul 0.10 -0.507
FY 2017 Apr '17 0.11 -0.440
Jan '17 0.25 -0.998
FY 2016 Sep '16 0.01 -1.268
Jun '16 0.01 -3.907
Mar '16 0.01 -3.513
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jan-18 1 5.40 5.40 5.40 --
Quarter Ending Apr-18 2 3.65 5.00 2.30 --
Year Ending Apr-18 2 7.25 8.60 5.90 --
Year Ending Apr-19 2 15.23 15.36 15.10 0.30
Year Ending Apr-20 2 26.90 43.80 10.00 30.30
Earnings (per share)
Quarter Ending Jan-18 1 -0.13 -0.13 -0.13 --
Quarter Ending Apr-18 2 -0.35 -0.26 -0.44 --
Year Ending Apr-18 2 -1.84 -1.74 -1.93 --
Year Ending Apr-19 2 -1.59 -1.49 -1.69 -3.15
Year Ending Apr-20 1 -0.60 -0.60 -0.60 -0.42
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.91 32.14
P/E High - Last 5 Yrs. -- 42.12 47.40
P/E Low - Last 5 Yrs. -- 23.53 24.78
Beta 3.08 0.90 0.87
Price to Sales (TTM) 22.99 4.10 6.23
Price to Book (MRQ) 6.62 3.41 3.80
Price to Tangible Book (MRQ) 10.52 4.89 5.78
Price to Cash Flow (TTM) -- 21.42 22.50
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.87 1.73
Dividend Yield - 5 Year Avg -- 1.53 1.45
Dividend 5 Year Growth Rate -- -8.49 -5.60
Payout Ratio(TTM) -- 49.49 46.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 3,772.92 5.63 8.41
Sales (TTM) vs TTM 1 Yr. Ago 2,484.09 4.62 6.69
Sales - 5 Yr. Growth Rate -- 6.96 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 8.20 18.81 25.39
EPS (TTM) vs TTM 1 Yr. Ago 53.00 -- --
EPS - 5 Yr. Growth Rate -- 6.42 7.57
Capital Spending - 5 Yr. Growth Rate -- 7.91 8.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.18
Current Ratio (MRQ) 2.41 2.92 2.95
LT Debt to Equity (MRQ) 0.00 9.04 11.33
Total Debt to Equity (MRQ) 0.82 11.34 14.17
Interest Coverage (TTM) -63.06 40.66 34.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.27 54.77
Gross Margin - 5 Yr. Avg. -- 53.28 53.26
EBITD Margin (TTM) -166.97 -- --
EBITD - 5 Yr. Avg -- 18.74 15.90
Operating Margin (TTM) -168.62 13.49 3.68
Operating Margin - 5 Yr. Avg. -- 14.31 11.01
Pre-Tax Margin (TTM) -132.38 13.84 3.97
Pre-Tax Margin - 5 Yr. Avg. -- 14.60 11.18
Net Profit Margin (TTM) -132.38 10.49 0.71
Net Profit Margin - 5 Yr. Avg. -- 10.90 7.52
Effective Tax Rate (TTM) -- 20.39 20.36
Effective Tax Rate - 5 Yr. Avg. -- 23.79 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 816,830,794 710,435,462
Net Income/Employee (TTM) -- 94,300,315 81,903,466
Receivable Turnover (TTM) 2.83 4.99 5.02
Inventory Turnover (TTM) -- 2.51 3.62
Asset Turnover (TTM) 0.27 0.83 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -35.99 9.93 9.68
Return on Assets - 5 Yr. Avg. -- 11.35 10.88
Return on Investment (TTM) -51.59 12.97 12.66
Return on Investment - 5 Yr. Avg. -- 14.67 14.01
Return on Equity (TTM) -60.04 14.97 14.84
Return on Equity - 5 Yr. Avg. -- 15.90 15.40
  1 Year 3 Year 5 Year
Sales % 458.11 -- --
EPS (TTM) % 61.75 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kalvista Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 59.44%
# of Holders: 36
Total Shares Held: 10,211,884
3 Mo. Net Change: 2,976,525
# New Positions: 6
# Closed Positions: 2
# Increased Positions: 16
# Reduced Positions: 8
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.